Parkman Healthcare Partners LLC - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 88 filers reported holding TRILLIUM THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.

Quarter-by-quarter ownership
Parkman Healthcare Partners LLC ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$2,050,000
+27.0%
211,385
+40.6%
0.45%
+19.5%
Q1 2021$1,614,000
-33.3%
150,304
-8.7%
0.38%
-39.5%
Q4 2020$2,421,000
-54.6%
164,585
-56.1%
0.62%
-56.1%
Q3 2020$5,330,000
+119.6%
375,063
+25.0%
1.41%
+106.3%
Q2 2020$2,427,000
+41.4%
300,000
-29.4%
0.68%
-14.1%
Q1 2020$1,717,000425,0000.80%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
NEA Management Company, LLC 2,100,000$646,0000.05%
Matrix Capital Management Company, LP 2,288,560$704,0000.02%
Tekla Capital Management LLC 446,099$137,0000.01%
Realta Investment Advisors 26,000$7,0000.00%
Virtu Financial LLC 34,991$11,0000.00%
Baker Brothers Advisors 505,262$155,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 20,044$6,0000.00%
MORGAN STANLEY 1,160,098$356,0000.00%
BANK OF MONTREAL /CAN/ 18,333$6,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 102,725$31,0000.00%
View complete list of TRILLIUM THERAPEUTICS INC shareholders